Government of Canada / Gouvernement du Canada
Symbol of the Government of Canada


Food and Drugs Act

Version of section 21.71 from 2019-06-21 to 2020-05-22:

Marginal note:Clinical trials and investigational tests

 The holder of a therapeutic product authorization referred to in paragraph 30(1.2)(c) shall ensure that prescribed information concerning the clinical trial or investigational test is made public within the prescribed time and in the prescribed manner.

  • 2014, c. 24, s. 3
  • 2019, c. 29, s. 168(F)

Date modified: